Solésence (SLSN)
Develops and manufactures mineral-UV skin-health formulations for brand partners.
Something off on this page? Send us feedback.
Supplies beauty and wellness partners with materials engineering, formulation development, and commercial manufacturing for skin-health products. Mineral-UV prestige skincare formulations with proprietary active pharmaceutical ingredients are its primary offering, alongside smaller legacy advanced-materials businesses.
Engineering materials, developing formulations, and manufacturing skin-health products for beauty and wellness brand partners are the core activities. Fully developed prestige skincare formulations with mineral UV protection and proprietary active pharmaceutical ingredients are the primary skin-health offering. Skin health is the current operating focus.
The business draws on materials-engineering capabilities that originated in nanocrystalline materials and uses them alongside formulation development and commercial manufacturing. The Solésence platform incorporates protection, prevention, and treatment technologies into daily-use products. Medical diagnostics, architectural and industrial coatings, abrasion-resistant additives, and plastics additives remain in the legacy advanced-materials category.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $1.0M · Total debt $22.7M · Total assets $46.4M · Shareholders' equity $13.2M
- Revenue
- $15.3M
- Operating income
- $121.0K
- Net income
- −$158.0K
No dividends on record.
| Insiders | 72.37% | 51.13M shares | |
|---|---|---|---|
| 2 holders · as of Dec 30, 2025 | |||
| Other | 27.63% | 19.52M shares | |
| remainder | |||
70.65M company shares as of Sep 22, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Bradford T. WhitmoreInsider10 percent owner | 69.42% | 49.04M | filed Jun 2, 2025 |
R. Janet WhitmoreInsiderdirector | 2.95% | 2.09M | filed Dec 30, 2025 |
John H Conley JrInsider | —3.70% of class, as filed | — | filed Jan 14, 2022 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Dec 24, 2025 | R. Janet Whitmore | director | +2,500 | $1.91 |
| Nov 14, 2025 | R. Janet Whitmore | director | +19,789 | $1.73 |
| Nov 17, 2025 | R. Janet Whitmore | director | +5,000 | $1.87 |
| Nov 18, 2025 | R. Janet Whitmore | director | +267 | $1.83 |
| Nov 19, 2025 | R. Janet Whitmore | director | +10,000 | $1.92 |
Not reported.